$19.8 Million
438 Thousand
0.57%
$33.7
Stanley Druckenmiller acquired 438 Thousand BridgeBio Pharma shares worth $19.8 Million. That's 0.57% of their equity portfolio (34th largest holding). The stake costed the investor $14.7 Million, netting the investor a gain of 34% so far.
Easily embed the chart on your blog or website – it will always update automatically!